This validates that 68Ga-SSO120 PET reliably visualizes SSTR2 expression in SCLC, so that PET imaging can be used to assess whole-body target expression and select patients in a theranostic setting. The gene discussed is SSTR2; the disease is small cell lung carcinoma.